Immunai

Immunai in the News

1 article

Big Tech's Billion-Dollar Blind Spot: Why AI Giants May Stumble in the Drug Development Race
Drug Discovery & Research

Big Tech's Billion-Dollar Blind Spot: Why AI Giants May Stumble in the Drug Development Race

Anthropic joins the pharma AI rush, but industry insiders warn that cracking molecular codes is the easy part—surviving clinical trials demands data these companies don't have.

Health AI Central Editorial Team·July 12, 2026